<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04096248</url>
  </required_header>
  <id_info>
    <org_study_id>H-37843</org_study_id>
    <nct_id>NCT04096248</nct_id>
  </id_info>
  <brief_title>CT (Computerized Tomography) for Late EndovasculAr Reperfusion</brief_title>
  <acronym>CLEAR</acronym>
  <official_title>Non-Contrast CT vs CTP or MRI Selection vs Medical Management in Late Presentation of Large Vessel Occlusion Stroke, 6-24 Hours. A Multicenter Retrospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Society of Vascular and Interventional Neurology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this multicenter, retrospective, cross-sectional, chart review study is to&#xD;
      compare outcomes (disability, complications and mortality) of patients with large vessel&#xD;
      occlusion stroke presenting at late time window selected by either Non-Contrast CT (NCCT)&#xD;
      only, advanced imaging with CTP (Computed Tomography Perfusion), MRI (Magnetic Resonance&#xD;
      Imaging), or medical management.&#xD;
&#xD;
      Boston Medical Center (BMC) will serve as the main data coordinating site. Fifteen additional&#xD;
      sites will seek local IRB approval or ethics approval. The aggregated de-identified data will&#xD;
      be analyzed comparing types of interventions and outcomes by type of imaging or medical&#xD;
      management.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Additional subgroup analysis that are planned include:&#xD;
&#xD;
        1. Futile Reperfusion in the Extended Window.&#xD;
&#xD;
           We will evaluate clinical, imaging and time metric factors associated with successful&#xD;
           reperfusion yet poor outcomes (modified Rankin 3-6) in the 6-24 hour window.&#xD;
&#xD;
           An evaluation of factors associated with symptomatic intracranial hemorrhage and&#xD;
           mortality will be conducted.&#xD;
&#xD;
        2. Transfer Analysis&#xD;
&#xD;
           It is not well established whether transfer patients presenting in the extended window&#xD;
           should have repeat imaging upon receipt at the endovascular center after an interim time&#xD;
           window.&#xD;
&#xD;
           We hypothesize that within a 0 to 2, or 2 to 4 hour delay between images of the primary&#xD;
           stroke center to receiving endovascular center, transferred patients in the extended&#xD;
           window, who undergo thrombectomy with successful reperfusion will have similar outcomes&#xD;
           in patients with or without repeat imaging at the receiving center.&#xD;
&#xD;
        3. Patients with pre-existing disability, defined as pre-stroke disability modified Rankin&#xD;
           score of 3 to 4.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 15, 2020</start_date>
  <completion_date type="Actual">May 23, 2021</completion_date>
  <primary_completion_date type="Actual">May 23, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in patients' disability based on a Modified Rankin Scale</measure>
    <time_frame>baseline, 90 days</time_frame>
    <description>The Modified Rankin Score (mRS) is a 6 point disability scale with possible scores ranging from 0 to 5. Lower scores correlate with less disability/dependence.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intracranial hemorrhage incidence</measure>
    <time_frame>90 days</time_frame>
    <description>Number of cases of intracranial hemorrhage divided by appropriate denominator.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality rate</measure>
    <time_frame>90 days</time_frame>
    <description>Number of deaths divided by appropriate denominator.</description>
  </secondary_outcome>
  <enrollment type="Actual">2790</enrollment>
  <condition>Stroke, Cardiovascular</condition>
  <eligibility>
    <study_pop>
      <textblock>
        At each of the 13 sites, retrospective chart abstraction will be done on all patients&#xD;
        treated with a large vessel occlusion stroke who meet the inclusion and none of the&#xD;
        exclusion criteria between January 1, 2014 and December 31, 2020.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients presenting 6-24 hours from last known well with large vessel occlusion stroke&#xD;
&#xD;
          -  ASPECTS score 5 or greater from last known well&#xD;
&#xD;
          -  January 1, 2014 to December 2020&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who have large vessel occlusion stroke of the posterior circulation&#xD;
&#xD;
          -  Time last seen well to treatment &lt;6 hours from last known well&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thanh Nguyen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Grady Health; Marcus Stroke &amp; Neuroscience Center</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Boston Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Massachusetts</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cooper University Health Care</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Upstate University Hospital</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kettering Health Network</name>
      <address>
        <city>Kettering</city>
        <state>Ohio</state>
        <zip>45429</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Toledo</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Health Neuroscience Institute</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de l'Universite de Montreal</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2X 0C1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universite de Lille</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heidelberg University</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Cerebral and Cardiovascular Center</name>
      <address>
        <city>Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Osaka National Hospital</name>
      <address>
        <city>Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Val D'Hebron</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bern University Hospital</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lausanne University Hospital</name>
      <address>
        <city>Lausanne</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>France</country>
    <country>Germany</country>
    <country>Japan</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 17, 2019</study_first_submitted>
  <study_first_submitted_qc>September 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 19, 2019</study_first_posted>
  <last_update_submitted>October 16, 2021</last_update_submitted>
  <last_update_submitted_qc>October 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Large vessel occlusion</keyword>
  <keyword>CT [Computed Tomography]</keyword>
  <keyword>CTP [Computed Tomography (CT) Perfusion]</keyword>
  <keyword>Modified Rankin score</keyword>
  <keyword>ASPECTS (Alberta Stroke Program Early CT Score)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

